Inogen | INGN - Sales Revenues


Inogen reported $74.93M in Sales Revenues for its fiscal quarter ending in September of 2024.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 141.2M 700K Mar/2026
Baxter International USD 2.7B 270M Mar/2026
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Boston Scientific USD 5.2B 90M Mar/2026
Chart Industries USD 884.8M 195.2M Mar/2026
Cooper Companies USD 1.08B 57.4M Mar/2026
Dexcom USD 1.19B 70M Mar/2026
Edwards Lifesciences USD 1.65B 80M Mar/2026
Globus Medical USD 759.85M 66.55M Mar/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 761.7M 22.1M Mar/2026
Medtronic USD 9.8B 800M Mar/2026
Orthofix International USD 219.91M 14.28M Dec/2025
Philips EUR 3.91B 1.19B Mar/2026
ResMed USD 1.4B 0 Mar/2026
Steris USD 1.59B 90M Mar/2026
Stryker USD 6B 1.2B Mar/2026
Tandem Diabetes Care USD 247.22M 43.18M Mar/2026
Teleflex USD 548.3M 20.68M Mar/2026
X T L Biopharmaceuticals USD 289K 127K Dec/2024
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026